Revogene® Strep A 410400
GUDID 00628055344179
The Revogene® Strep A assay, performed on the Revogene® instrument, is an automated, qualitative in vitro diagnostic test that utilizes real-time polymerase chain reaction (PCR) for the direct detection of Streptococcus pyogenes (Group A B-hemolytic Streptococcus) nucleic acids from throat swab specimens obtained from patients with signs and symptoms of pharyngitis. The Revogene Strep A assay is intended for use as an aid in the diagnosis of Group A Streptococcus infection.
Meridian Bioscience Canada Inc
Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)| Primary Device ID | 00628055344179 |
| NIH Device Record Key | 46f8fac7-4683-4201-a413-de898384c8a3 |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | Revogene® Strep A |
| Version Model Number | 410400 |
| Catalog Number | 410400 |
| Company DUNS | 204006360 |
| Company Name | Meridian Bioscience Canada Inc |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | false |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | true |
| Device Combination Product | false |
| Single Use | true |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
Customer Support Contacts
Operating and Storage Conditions
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
| Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Device Identifiers
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 00628055344179 [Primary] |
FDA Pre-market Approvals/Notifications & deNovo
- Premarket Notification: K183366
FDA Product Code
| PGX | Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System |
Sterilization
| Steralize Prior To Use | false |
| Device Is Sterile | false |
Device Entry Metadata
| Public Version Status | New |
| Device Record Status | Published |
| Public Version Number | 1 |
| Public Version Date | 2019-10-29 |
| Device Publish Date | 2019-10-21 |
Devices Manufactured by Meridian Bioscience Canada Inc
| 00628055344100 - Revogene® | 2019-11-11 The Revogene® instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assay |
| 00628055344117 - Revogene® GBS LB | 2019-10-29 The Revogene® GBS LB assay performed on the Revogene instrument is a qualitative in vitro diagnostic test designed to detect Gr |
| 00628055344124 - Revogene® C. difficile | 2019-10-29 The Revogene® C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes a |
| 00628055344131 - MOCK PIE | 2019-10-29 The MOCK PIE is a re-usable PIE intended for use in conjunction with the Revogene® instrument and Revogene® assays. The MOCK P |
| 00628055344162 - Revogene® Carba C | 2019-10-29 The Revogene® Carba C assay, performed on the Revogene® instrument, is a qualitative in vitro diagnostic test designed for the |
| 00628055344179 - Revogene® Strep A | 2019-10-29The Revogene® Strep A assay, performed on the Revogene® instrument, is an automated, qualitative in vitro diagnostic test that utilizes real-time polymerase chain reaction (PCR) for the direct detection of Streptococcus pyogenes (Group A B-hemolytic Streptococcus) nucleic acids from throat swab specimens obtained from patients with signs and symptoms of pharyngitis. The Revogene Strep A assay is intended for use as an aid in the diagnosis of Group A Streptococcus infection. |
| 00628055344179 - Revogene® Strep A | 2019-10-29 The Revogene® Strep A assay, performed on the Revogene® instrument, is an automated, qualitative in vitro diagnostic test that |
Trademark Results [Revogene]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 REVOGENE 87514391 5784546 Live/Registered |
Genepoc Inc. 2017-07-03 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.